Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

milpharm limited - pravastatin sodium - tablets - 10 milligram - hmg coa reductase inhibitors

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

milpharm limited - pravastatin sodium - tablets - 40 milligram - hmg coa reductase inhibitors

Malta - Inggeris - Medicines Authority

accord healthcare limited - pravastatin sodium - tablet - pravastatin sodium 10 mg - lipid modifying agents

Malta - Inggeris - Medicines Authority

accord healthcare limited - pravastatin sodium - tablet - pravastatin sodium 20 mg - lipid modifying agents

Malta - Inggeris - Medicines Authority

accord healthcare limited - pravastatin sodium - tablet - pravastatin sodium 40 mg - lipid modifying agents

Malta - Inggeris - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pravastatin sodium - tablet - pravastatin sodium 10 mg - lipid modifying agents

Malta - Inggeris - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pravastatin sodium - tablet - pravastatin sodium 20 mg - lipid modifying agents

Malta - Inggeris - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pravastatin sodium - tablet - pravastatin sodium 40 mg - lipid modifying agents

United Kingdom - Inggeris - myHealthbox

milpharm limited - pravastatin sodium - tablets - 10mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors

United Kingdom - Inggeris - myHealthbox

milpharm limited - pravastatin sodium - tablets - 20mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors